3,841 Shares in Agilent Technologies, Inc. $A Acquired by Northwestern Mutual Wealth Management Co.

Northwestern Mutual Wealth Management Co. bought a new stake in shares of Agilent Technologies, Inc. (NYSE:A) in the 2nd quarter, HoldingsChannel reports. The firm bought 3,841 shares of the medical research company’s stock, valued at approximately $510,000.

A number of other large investors have also recently added to or reduced their stakes in A. Mitsubishi UFJ Asset Management Co. Ltd. raised its position in Agilent Technologies by 4.3% during the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 599,581 shares of the medical research company’s stock valued at $82,712,000 after buying an additional 24,687 shares during the period. Dudley & Shanley Inc. boosted its position in Agilent Technologies by 25.9% during the 2nd quarter. Dudley & Shanley Inc. now owns 69,500 shares of the medical research company’s stock worth $9,232,000 after acquiring an additional 14,300 shares during the period. BIP Wealth LLC purchased a new position in Agilent Technologies during the 2nd quarter valued at about $834,000. Crossmark Global Holdings Inc. grew its stake in Agilent Technologies by 39.6% during the 4th quarter. Crossmark Global Holdings Inc. now owns 33,918 shares of the medical research company’s stock valued at $4,615,000 after acquiring an additional 9,615 shares in the last quarter. Finally, Capricorn Fund Managers Ltd acquired a new position in shares of Agilent Technologies in the 1st quarter valued at about $8,161,000.

Agilent Technologies Price Performance

NYSE A opened at $155.16 on Thursday. The company has a quick ratio of 1.62, a current ratio of 2.10 and a debt-to-equity ratio of 0.43. The stock has a market capitalization of $43.82 billion, a PE ratio of 31.16, a price-to-earnings-growth ratio of 2.73 and a beta of 1.25. Agilent Technologies, Inc. has a 12-month low of $108.35 and a 12-month high of $160.51. The company has a 50 day moving average price of $139.16 and a two-hundred day moving average price of $126.65.

Agilent Technologies (NYSE:A) last announced its quarterly earnings results on Wednesday, August 26th. The medical research company reported $1.62 EPS for the quarter, topping the consensus estimate of $1.49 by $0.13. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The company had revenue of $1.88 billion for the quarter, compared to analyst estimates of $1.84 billion. During the same quarter in the prior year, the business posted $1.37 EPS. Agilent Technologies’s quarterly revenue was up 8.1% on a year-over-year basis. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. As a group, equities analysts predict that Agilent Technologies, Inc. will post 6.05 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several analysts recently commented on A shares. Barclays raised their price target on shares of Agilent Technologies from $145.00 to $150.00 and gave the stock an “overweight” rating in a report on Wednesday, June 24th. Wall Street Zen upgraded shares of Agilent Technologies from a “hold” rating to a “buy” rating in a research report on Sunday, August 2nd. Weiss Ratings raised shares of Agilent Technologies from a “hold (c-)” rating to a “hold (c)” rating in a research note on Tuesday, June 2nd. Morgan Stanley boosted their price target on shares of Agilent Technologies from $160.00 to $175.00 and gave the company an “overweight” rating in a report on Wednesday, August 12th. Finally, Piper Sandler initiated coverage on Agilent Technologies in a report on Thursday, June 11th. They set a “neutral” rating and a $150.00 price objective for the company. Two analysts have rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $160.24.

Key Stories Impacting Agilent Technologies

Here are the key news stories impacting Agilent Technologies this week:

• Positive Sentiment: Agilent reported fiscal Q3 revenue of $1.88 billion, up 8.1% year over year and ahead of the roughly $1.84 billion consensus estimate. Adjusted EPS of $1.62 exceeded estimates near $1.48-$1.49 and rose from $1.37 a year earlier. Agilent Technologies Q3 Earnings and Revenues Top Estimates
• Positive Sentiment: Profitability and cash generation strengthened. Operating profit increased 23.3% to $444 million, operating cash flow rose 43.4% to $519 million, and the company ended the quarter with $1.8 billion in cash. GAAP net income reached $362 million, or $1.28 per diluted share, versus $336 million, or $1.18, a year earlier. Agilent Reports Third-Quarter Fiscal Year 2026 Financial Results
• Positive Sentiment: Agilent raised fiscal 2026 adjusted EPS guidance to $6.18-$6.21, above the approximately $6.06 consensus, and projected revenue of about $7.5 billion versus expectations near $7.4 billion. Management cited improving laboratory-tools demand. Fourth-quarter guidance was broadly in line with analyst estimates. Agilent Raises Annual Profit Forecast
• Neutral Sentiment: Institutional investor positioning was mixed: 594 investors increased holdings in the latest quarter, while 550 reduced positions. Recent analyst targets have a median of $155, suggesting limited near-term upside relative to the recent trading level.
• Negative Sentiment: Despite the earnings beat, Agilent trades at a relatively demanding valuation, with a P/E ratio above 31, and the stock is close to its 12-month high. This could make the shares more sensitive to any slowdown in laboratory-equipment demand or future guidance disappointments.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.